Company Information & Financial DataMi-Trial Limited
Registered address:
Directors
Current | Date Appointed |
---|---|
Reveal name
Manchester, Greater Manchester, M23
|
14 Oct 2022 |
Reveal name
Manchester, Greater Manchester, M23
|
01 Oct 2021 |
Reveal name
Manchester, Greater Manchester, M23
|
01 Oct 2021 |
Reveal name
Sheffield, South Yorkshire, S1
|
14 Oct 2022 |
Source: Companies House
Summary Balance Sheet
For more information on Abbreviated Accounts please click here:
http://www.companieshouse.gov.uk/about/gbhtml/gp2.shtml#ch6
Years
Net Worth Cash
31 Oct 2022
£ |
31 Mar 2023
£ |
||
---|---|---|---|
Total Asset |
31 Oct 2022
31 Mar 2023
|
£13,360 | £13,360 |
Current Asset |
31 Oct 2022
31 Mar 2023
|
£13,260 | £13,260 |
Current Liabilities |
31 Oct 2022
31 Mar 2023
|
£13,260 | £13,260 |
Net Current Assets |
31 Oct 2022
31 Mar 2023
|
£100 | £100 |
Net Current Liabilities |
31 Oct 2022
31 Mar 2023
|
£13,260 | £2,514 |
Net Worth |
31 Oct 2022
31 Mar 2023
|
£100 | £100 |
Cash |
31 Oct 2022
31 Mar 2023
|
N/A | N/A |
Profit & Loss Reserve |
31 Oct 2022
31 Mar 2023
|
£100 | £100 |
Source: Companies House
Other Businesses At This Address
Company Name | Classification | Company Number |
---|---|---|
Medicines Evaluation Unit
|
Research and Laboratory Based Activities | 03779957 |
Axalbion Therapeutics Limited
|
Pharmaceutical Products Manufacturers of | 13224059 |
North West Lung Centre
T:
0161 946 4058
|
Alternative Medical Treatments and Therapies | 03936652 |
Key: N/A = Not Available